References
- Aceto M. D., Martin B. R. Central actions of nicotine. Medical Research Reviews 1982; 2: 43–62
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Ed. 3. Washington, DC 1980
- Andersen A. N., Semczuk M., Tabor A. Prolactin and pituitary-gonadal function in cigarette smoking infertile patients. Andrologia 1984; 16: 391
- Baron J. A. Cigarette smoking and Parkinson's disease. Neurology 1986; 36: 1490–1496
- Cash R., Dennis T., L'Heureux R., Raisman R., Javoy-Agid F., Scatton B. Parkinson's disease and dementia: Norepinephrine and dopamine in locus coeruleus. Neurology 1987; 37: 42–46
- Cryer P. E., Haymend M. W., Santiago J. V., Shah S. D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. New England Journal of Medicine 1976; 295: 573–577
- Davis J. M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry. 1976; 33: 858–861
- Growdon J. H., Corkin S. Cognitive impairments in Parkinson's disease. Advances in Neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 383–392
- Jaffe J. H., Jarvik M. E. Tobacco use and tobacco use disorder. Psychopharmacology: a generation of progress, M. A. Lipton, A. DiMascio, K. F. Killam. Raven Press, New York 1978; 1665–1676
- Korczyn A. D., Inzelberg R., Treves T., Neufeld M., Reider I., Rabey P. M. Dementia of Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 399–403
- Lichtensteiger W., Hefti F., Felix D. Stimulation of nigrostriatal dopamine neurons by nicotine. Neuropharmacology 1982; 21: 963–968
- Mann D. M. A., Yates P. O., Hawkes J. The pathology of the human locus ceruleus. Clinical Neuropathology 1983; 2: 1–7
- Naquira D., Zunino E., Arqueros L., Viveros O. H. Chronic effects of nicotine on catecholamine synthesizing enzymes in rats. European Journal of Pharmacology 1978; 47: 227–229
- Patrick R. L., Kirschner N. Effect of stimulation on the levels of tyrosine hydroxylase, dopamine beta-hydroxylase, and catecholamines in intact and denervated rat adrenal glands. Molecular Pharmacology 1971; 7: 87–96
- Silvette H., Larson P. S., Haag H. B. Action of nicotine and tobacco-smoking on the adrenal medulla. Archives of Internal Medicine 1961; 107: 181–197
- Simpson G. M., Angus J. W. S. Drug-induced extrapyramidal disorders. Acta Psychiatrica Scandinavica 1970; 212: 1–58, (suppl)
- Slotkin T. A., Sleider F. J. Effects of chronic nicotine administration on the denervated rat adrenal medulla. British Journal of Pharmacology 1975; 56: 201–207
- Stem Y., Mayeux R. Intellectual impairment in Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; Vol. 45: 405–408
- Stem Y., Mayeux R., Cote L. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Archives of Neurology 1984; 41: 1086–1089
- Waddington J. L., Youssef H. A. An unusual cluster of tardive dyskinesia in schizophrenia: Association with cognitive dysfunction and negative symptoms. American Journal of Psychiatry 1986; 143: 1162–1165
- Westfall T. C., Watts D. T. Effect of cigarette smoke on epinephrine secretion in the dog. Proceedings of the Society of Experimental Biology and Medicine 1963; 112: 843–847
- Westfall T. C., Watts D. T. Catecholamine secretion in smokers and nonsmokers. Journal of Applied Physiology 1964; 19: 40–42
- Whitehouse P. J. Clinical and neurochemical consequences of neuronal loss in the nucleus baslais of Meynert in Parkinson's disease and Alzheimer's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; Vol. 45: 393–397
- Winblad B., Adolfsson R., Carlsson A. Biogenic amines in brains of patients with Alzheimer's disease. Alzheimer's disease: a report of progress in research, S. Corkin, K. L. Davis, J. H. Crowdon. Raven Press, New York 1982; 25–33